Merck Maintains Merger-Free Philosophy; Co-Promotions Also Ruled Out
Executive Summary
Merck will refrain from entering into co-promotion agreements to take advantage of its sales force capacity, CEO Raymond Gilmartin told securities analysts Dec. 9 at the company's Whitehouse Station, N.J. headquarters.
You may also be interested in...
Merck Drops Strict “No Merger” Policy, But Still Prefers Licensing Deals
Merck appears to be distancing itself from a blanket "no merger" policy by offering a formula under which it would consider a large-scale transaction
Merck Drops Strict “No Merger” Policy, But Still Prefers Licensing Deals
Merck appears to be distancing itself from a blanket "no merger" policy by offering a formula under which it would consider a large-scale transaction
Merck/Schering Ezetimibe Deal Is Part Of Growing Ties Between Firms
Merck is edging away from its strict go-it-alone policy and sidling up a little closer to Schering-Plough in a series of deals - the most recent of which is a co-promotion agreement with Schering-Plough for the Phase III cholesterol absorption inhibitor ezetimibe.